Results 151 to 160 of about 3,382,864 (170)

Impact of Cytokeratin 19 Expression on the Outcomes of Unresectable Hepatocellular Carcinoma Treated with Targeted Therapy and Immunotherapy: A Propensity Score Matched Analysis. [PDF]

J Hepatocell Carcinoma
Liu J, Yuan T, Lv X, Tan G, Xue L, Huang Z.   +5 more
europepmc   +1 more source

NF-κB inducing kinase (NIK) deletion accelerates KRAS-driven pancreatic cancer in association with tumor microenvironment remodeling. [PDF]

Cell Death Dis
Du Z, Büttner UFG, Wirth HL, Gerstenlauer M, Manfras U, Loidl R, Bahçeci D, Steiger K, Metzler T, Chan LK, Tsesmelis M, Wirth T.   +11 more
europepmc   +1 more source

Immunohistochemical expression of SMAD4, CK19, and CA19-9 in fine needle aspiration samples of pancreatic adenocarcinoma: Utility and potential role

CytoJournal, 2007
Background Pancreatic adenocarcinoma comprises 85% of all cases of pancreatic malignancies. From a diagnostic standpoint, these tumors are readily diagnosed by fine needle aspiration, with an accuracy of greater than 90%; however it is often difficult to ascertain whether these are primary or metastatic in nature.
Momin T Siddiqui
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Diagnostic value of differential expression of CK19, galectin-3, HBME-1, ERK, RET, and p16 in benign and malignant follicular-derived lesions of the thyroid: An immunohistochemical tissue microarray analysis

Endocrine Pathology, 2006
Several immunohistochemical markers have been used to aid in the diagnosis of follicular-derived lesions of the thyroid (FDLT). In this study we analyze the diagnostic efficacy of an immunopanel of antibodies to cytokeratin-19 (CK19), galectin-3 (GAL-3), HBME-1, anti-MAP kinase (ERK), ret-oncoprotein (RET), and p16 using a tissue microarray consisting ...
Zubair W Baloch, Virginia LiVolsi, P Lal
exaly   +3 more sources

Evaluation of the immunohistochemical expression of Nrf2, galectin-3, and CK19 in papillary thyroid carcinoma and its mimics

Egyptian Journal of Pathology
Background The increasing incidence of papillary thyroid carcinoma (PTC) and inadequacy of routine histological examination in diagnosis and differentiation from its mimics necessitate the application of immunohistochemistry to deal with this issue.
Dalia M Abouelfadl
exaly   +2 more sources

Expression of CK19 and KIT in resectable pancreatic neuroendocrine tumors

Tumor Biology, 2013
Wenhui Lou, Xu Han, Yuan Ji
exaly  

Proposed histopathologic grading system derived from a study of KIT and CK19 expression in pancreatic endocrine neoplasm

Human Pathology, 2011
Lizhi Zhang, Christine M. Lohse, Linda N Dao   +2 more
exaly  

Immunohistochemical markers in diagnosis of papillary thyroid carcinoma: utility of HBME1 combined with CK19 immunostaining

Modern Pathology, 2006
Sanjay Mukhopadhyay, Shengle Zhang, Anna-Luise A Katzenstein   +2 more
exaly  

CK19 and CD10 expression in pancreatic neuroendocrine tumors diagnosed by endoscopic ultrasound-guided fine-needle aspiration cytology

Cancer Cytopathology, 2009
Charitini Salla, Paschalis Chatzipantelis   +1 more
exaly  

Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor

Cancer, 2008
Xiao-Dong Zhu, Wei-Zhong Wu, Zhao-You Tang   +2 more
exaly